Aliases & Classifications for Bronchial Disease

MalaCards integrated aliases for Bronchial Disease:

Name: Bronchial Disease 12 15 17
Bronchial Diseases 56 45 74
Bronchospasm 12 15
Bronchial Disorders 44
Bronchial Spasm 74

Classifications:



External Ids:

Disease Ontology 12 DOID:1176
MeSH 45 D001982
SNOMED-CT 69 41427001

Summaries for Bronchial Disease

MedlinePlus : 44 When you breathe in, the air travels down through your trachea (windpipe). It then goes through two tubes to your lungs. These tubes are your bronchi. Bronchial disorders can make it hard for you to breathe. The most common problem with the bronchi is bronchitis, an inflammation of the tubes. It can be acute or chronic. Other problems include Bronchiectasis - a condition in which damage to the airways causes them to widen and become flabby and scarred Exercise-induced bronchospasm - a breathing problem that happens when your airways shrink while you are exercising Bronchiolitis - an inflammation of the small airways that branch off from the bronchi Bronchopulmonary dysplasia - a chronic lung condition in infants, most often premature infants

MalaCards based summary : Bronchial Disease, also known as bronchial diseases, is related to bronchitis and bronchiectasis, and has symptoms including dyspnea, apnea and snoring. An important gene associated with Bronchial Disease is ELANE (Elastase, Neutrophil Expressed), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Budesonide and Tobramycin have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and trachea, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A lower respiratory tract disease that affects the airways leading into the lungs, which is caused due to inflammation of the bronchi and bronchioles, infection, or blockage.

Wikipedia : 77 A bronchus is a passage of airway in the respiratory system that conducts air into the lungs. The first... more...

Related Diseases for Bronchial Disease

Diseases related to Bronchial Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 194)
# Related Disease Score Top Affiliating Genes
1 bronchitis 32.4 CCL11 CXCL8 ELANE IL5 RNASE3 TNF
2 bronchiectasis 32.1 CXCL8 ELANE SERPINA3
3 asthma 31.2 ADAM33 ADRB2 CCL11 CCL5 CXCL8 CYSLTR1
4 ige responsiveness, atopic 30.6 ADRB2 IL13 IL4 IL5 MS4A2 RNASE3
5 churg-strauss syndrome 30.5 IL5 RNASE3 TNF
6 allergic rhinitis 30.4 CCL11 CXCL8 IL13 IL4 IL5 MS4A2
7 pulmonary tuberculosis 30.4 IFNGR1 IL4 TNF
8 rhinitis 30.4 CCL11 CCL5 CXCL8 CYSLTR1 IL13 IL4
9 respiratory failure 30.3 CXCL8 ELANE TNF
10 status asthmaticus 30.2 ADRB2 CCL5 CXCL8 ELANE IL5 RNASE3
11 interstitial lung disease 30.1 CCL5 CXCL8 IL4 TNF
12 bronchiolitis 30.0 CCL11 CCL5 CXCL8 IL13 IL4 IL5
13 allergic asthma 29.9 ADAM33 CCL11 CCL5 IL13 IL4 IL5
14 cystic fibrosis 29.7 ADRB2 CXCL8 ELANE RNASE3
15 pulmonary disease, chronic obstructive 29.7 ADAM33 ADRB2 CCL11 CCL5 CXCL8 ELANE
16 lung disease 29.6 ADRB2 CCL5 CXCL8 ELANE IL13 IL5
17 sudden infant death with dysgenesis of the testes syndrome 11.2
18 aspiration pneumonitis 11.1
19 cytokine deficiency 10.6 IL13 IL5
20 nickel allergic contact dermatitis 10.5 IL13 IL4 IL5
21 paragonimiasis 10.5 IL13 IL5 RNASE3
22 apple allergy 10.5 IL13 IL4 IL5
23 cough variant asthma 10.5 IL4 IL5 RNASE3
24 milk allergy 10.5 IL4 IL5 RNASE3
25 atopic keratoconjunctivitis 10.5 IL4 IL5 RNASE3
26 chronic tic disorder 10.5 IL13 IL4 IL5
27 intrinsic asthma 10.5 IL4 IL5 RNASE3
28 tropical endomyocardial fibrosis 10.5 IL4 TNF
29 endomyocardial fibrosis 10.5 IL4 TNF
30 papillary conjunctivitis 10.5 CCL11 CXCL8 IL4
31 strongyloidiasis 10.5 CCL11 IL13 IL5
32 enterobiasis 10.5 IL13 IL4 IL5
33 blepharoconjunctivitis 10.5 CCL11 IL4 RNASE3
34 pollen allergy 10.5 IL13 IL5 RNASE3
35 angioimmunoblastic lymphadenopathy with dysproteinemia 10.5 IL13 IL5 TNF
36 exudative glomerulonephritis 10.5 CXCL8 TNF
37 paranasal sinus disease 10.5 IL13 IL4 IL5
38 night blindness, congenital stationary, type 1a 10.5 CCL11 IL13 IL5
39 ascaris lumbricoides infection 10.5 IL13 IL5 TSLP
40 mycobacterium fortuitum 10.5 CXCL8 IFNGR1
41 scleritis 10.5 IL4 IL5 TNF
42 loeffler endocarditis 10.5 IL5 RNASE3
43 cow milk allergy 10.5 IL5 RNASE3 TNF
44 wells syndrome 10.5 CXCL8 IL5 RNASE3
45 respiratory syncytial virus infectious disease 10.5 CCL5 IL13 IL5
46 vernal conjunctivitis 10.5 IL4 MS4A2 RNASE3
47 tungiasis 10.5 CXCL8 IL4 TNF
48 bronchopulmonary dysplasia 10.5 CXCL8 ELANE RNASE3
49 mycoplasma pneumoniae pneumonia 10.5 IL13 IL4 TNF
50 pemphigoid gestationis 10.5 CCL11 IL5

Graphical network of the top 20 diseases related to Bronchial Disease:



Diseases related to Bronchial Disease

Symptoms & Phenotypes for Bronchial Disease

UMLS symptoms related to Bronchial Disease:


dyspnea, apnea, snoring, wheezing, coughing, expiratory wheeze, inspiratory wheeze

MGI Mouse Phenotypes related to Bronchial Disease:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10 ADRB2 CCL11 CCL5 CCR6 ELANE IFNGR1
2 immune system MP:0005387 9.83 ADRB2 CCL11 CCL5 CCR6 CYSLTR1 ELANE
3 digestive/alimentary MP:0005381 9.8 IFNGR1 IL13 IL33 IL4 IL5 TNF
4 respiratory system MP:0005388 9.28 CCL11 CYSLTR1 IL13 IL33 IL4 IL5

Drugs & Therapeutics for Bronchial Disease

Drugs for Bronchial Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 688)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Budesonide Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 51333-22-3 63006 5281004
2
Tobramycin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 32986-56-4 5496 36294
3
Amikacin Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 37517-28-5 37768
4
Bromhexine Approved Phase 4 3572-43-8
5
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 329-65-7 838
6
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-43-4 5816
7
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 10102-43-9 145068
8
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 7487-88-9 24083
9
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
10
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
11
Ipratropium Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 60205-81-4, 22254-24-6 43232 657309
12
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
13
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
14
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 94-09-7, 1994-09-7 2337
15
Remifentanil Approved Phase 4 132875-61-7 60815
16
Etomidate Approved Phase 4 33125-97-2 36339 667484
17
tannic acid Approved Phase 4,Phase 3,Phase 2,Not Applicable 1401-55-4
18
Cisatracurium Approved Phase 4 96946-41-7
19
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 68602 5311068
20
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 437-38-7 3345
21
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
22
Midazolam Approved, Illicit Phase 4,Phase 1,Not Applicable 59467-70-8 4192
23
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 2078-54-8 4943
24
Montelukast Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 158966-92-8 5281040
25
mometasone furoate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 83919-23-7
26
Terbutaline Approved Phase 4,Phase 3,Phase 2,Not Applicable 23031-25-6 5403
27
Omalizumab Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 242138-07-4
28
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 299-42-3 9294
29
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 90-82-4 7028
30
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 93-14-1 3516
31
Procaterol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 72332-33-3 688561
32
Fluticasone Approved, Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90566-53-3 62924
33
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53-03-2 5865
34
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
35
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 138530-94-6, 103577-45-3 9578005
36
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83905-01-5 55185 447043
37
Acetylcysteine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 616-91-1 12035
38
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 100986-85-4 149096
39
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Not Applicable 82419-36-1 4583
40
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
41
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1177-87-3
42
Ciclesonide Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 141845-82-1, 126544-47-6 444033
43
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 51-45-6 774
44
Citalopram Approved Phase 4,Not Applicable 59729-33-8 2771
45
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-23-7 5754
46
Hydrocortisone acetate Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-03-3
47
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-78-2 2244
48
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Not Applicable 26787-78-0 33613
49
Clavulanate Approved, Vet_approved Phase 4,Phase 3,Not Applicable 58001-44-8 5280980
50
Metronidazole Approved Phase 4,Not Applicable 443-48-1 4173

Interventional clinical trials:

(show top 50) (show all 3158)
# Name Status NCT ID Phase Drugs
1 Comparisons of Inhaled LAMA or ICS+LABA for COPD With Bronchiectasis Unknown status NCT02546297 Phase 4 Symbicort;Tiotropium Bromide
2 Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis Unknown status NCT02507843 Phase 4 Cholecalciferol;Placebo
3 A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis Unknown status NCT01677403 Phase 4 Tobramycin;Saline
4 Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis Unknown status NCT02081963 Phase 4 Amikacin;Normal saline
5 Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography Unknown status NCT01361984 Phase 4 Nebulized arformoterol;Salmeterol
6 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
7 High Flow Nasal Cannula vs Low Flow Oxygen Therapy in Bronchiolitis Unknown status NCT03015051 Phase 4 Oxygen
8 Home Oxygen Therapy in Bronchiolitis Unknown status NCT01216553 Phase 4
9 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4 Racemic adrenaline;Isotonic saline
10 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
11 Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis Unknown status NCT03132623 Phase 4 andrographolide sulfonate;andrographolide sulfonate simulation
12 A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis Unknown status NCT03132610 Phase 4 andrographolide sulfonate;andrographolide sulfonate simulation
13 Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients Unknown status NCT02934945 Phase 4 budesonide 160μg/formoterol 4.5μg
14 Low Exhaled NO and ICS in Suspected Asthma Unknown status NCT02771717 Phase 4 Budesonide (Pulmicort);Placebo - dummy inhaler
15 Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation Unknown status NCT02584738 Phase 4 Nebulized Magnesium Sulfate;Nebulized isotonic saline;Nebulized Salbutamol;Ipratropium bromide;Methylprednisolone or Prednisolone
16 Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis Unknown status NCT02345993 Phase 4 Extra fine Formoterol/Beclomethasone
17 Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia Unknown status NCT02289391 Phase 4 Anesthesia induction;Anesthesia maintenance;Assisted anesthesia
18 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4 Montelukast;mometasone furoate nasal spray
19 Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital Unknown status NCT02053402 Phase 4 Vitamin D
20 Efficacy of Bronchial Thermoplasty in Korean Unknown status NCT02031263 Phase 4
21 The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Unknown status NCT02002754 Phase 4 Bambuterol Hydrochloride tablets
22 Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients Unknown status NCT02002715 Phase 4 Inhaled budesonide
23 Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma. Unknown status NCT01939951 Phase 4
24 Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma Unknown status NCT01912872 Phase 4 Omalizumab;Budesonide;Formoterol
25 Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home Unknown status NCT01783132 Phase 4
26 Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma Unknown status NCT01584804 Phase 4 Su-Huang antitussive capsule;Sugar pill
27 Assessing Decision Maker Tools for Asthma: the Asthma APGAR Unknown status NCT01446315 Phase 4
28 Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma Unknown status NCT01404013 Phase 4 ICS/LABA;Montelukast;ICS/LABA and Montelukast
29 Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA) Unknown status NCT01170429 Phase 4 Procaterol hydrochloride;Meptin placebo
30 Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis Unknown status NCT01121016 Phase 4 Montelukast
31 Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites Unknown status NCT01052610 Phase 4 sublingual house dust mites allergen extract;placebo in sublingual applicator
32 Concentrations of Salmeterol in Blood and Urine Unknown status NCT00914901 Phase 4 inhaled salmeterol
33 Terbutaline Concentrations in Blood and Urine Unknown status NCT00914797 Phase 4 inhaled and oral terbutaline
34 Concentrations of Formoterol in Blood and Urine Unknown status NCT00914654 Phase 4 inhaled formoterol
35 Rapid Onset Action of Salbutamol Versus Formoterol Unknown status NCT00900874 Phase 4 salbutamol;Formoterol
36 Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma Unknown status NCT00830505 Phase 4 fluticasone/ salmeterol;fluticasone
37 Vitamin D for the Treatment of Severe Asthma Unknown status NCT00712205 Phase 4 Placebo;Calcitriol
38 A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children Unknown status NCT00624429 Phase 4 Budesonide respules
39 Inflammatory, Functional and Image Composite Measure to Define Asthma Control Unknown status NCT00597064 Phase 4 prednisone
40 Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma Unknown status NCT00500253 Phase 4
41 Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma Unknown status NCT00496574 Phase 4
42 Effect of Specific Immunotherapy to Dust Mites in Children With Asthma Unknown status NCT00496561 Phase 4
43 Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids Unknown status NCT00397267 Phase 4 inhalation of corticosteroids
44 A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control Unknown status NCT00385359 Phase 4 Albuterol
45 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
46 Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID Unknown status NCT00235053 Phase 4 fluticasone/salmeterol DISKUS 250/50
47 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
48 Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation Completed NCT01403467 Phase 4
49 Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis Completed NCT02782312 Phase 4 ICS+LABA
50 Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm Completed NCT02182713 Phase 4 Salbutamol sulfate/Ipratropium bromide;Salbutamol

Search NIH Clinical Center for Bronchial Disease

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: bronchial diseases

Genetic Tests for Bronchial Disease

Anatomical Context for Bronchial Disease

MalaCards organs/tissues related to Bronchial Disease:

42
Lung, Testes, Trachea, T Cells, Bone, Heart, Neutrophil

Publications for Bronchial Disease

Articles related to Bronchial Disease:

(show top 50) (show all 63)
# Title Authors Year
1
Male patient with chronic bronchial disease and bullous emphysema superinfection. ( 29703394 )
2018
2
Metallic small y stent placement at primary right carina for bronchial disease. ( 30497447 )
2018
3
Novel Mutation of Interferon-I^ Receptor 1 Gene Presenting as Early Life Mycobacterial Bronchial Disease. ( 27868075 )
2016
4
A case of IgG4-related bronchial disease successfully treated with inhaled corticosteroids. ( 26441152 )
2015
5
Progression and prognostic indicators of bronchial disease in children with sickle cell disease. ( 24699774 )
2014
6
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype. ( 24591669 )
2014
7
Correlation of bronchoalveolar eosinophilic percentage with airway responsiveness in cats with chronic bronchial disease. ( 23617298 )
2013
8
'Heavier the interval than the consummation': bronchial disease in Sean O Riordain's diaries. ( 24002457 )
2013
9
Lower respiratory tract endoscopy in the cat: diagnostic approach to bronchial disease. ( 24152702 )
2013
10
Inhaled budesonide therapy in cats with naturally occurring chronic bronchial disease (feline asthma and chronic bronchitis). ( 24000786 )
2013
11
Use of propentofylline in feline bronchial disease: prospective, randomized, positive-controlled study. ( 20810552 )
2010
12
Radiographic abnormalities in cats with feline bronchial disease and intra- and interobserver variability in radiographic interpretation: 40 cases (1999-2006). ( 19210258 )
2009
13
Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. ( 16860549 )
2009
14
Tobacco as an allergen in bronchial disease. ( 17458428 )
2007
15
The nose: gatekeeper and trigger of bronchial disease. ( 17020064 )
2006
16
Twenty-five cases of feline bronchial disease (1995-2000). ( 15135355 )
2004
17
Bronchial diseases and lung aeration in children. ( 11685087 )
2001
18
Flexible bronchoscopy: a safe method for metal stent implantation in bronchial disease. ( 10735670 )
2000
19
The role of airway stents in the management of pediatric tracheal, carinal, and bronchial disease. ( 11053808 )
2000
20
Elastic deformation properties of implanted endobronchial wire stents in benign and malignant bronchial disease: A radiographic in vivo evaluation. ( 10094988 )
1999
21
Pneumocystis carinii infection in patients with chronic bronchial disease. ( 8598795 )
1996
22
Atypical bronchoplasty to lung cancer and benign bronchial disease. ( 8073432 )
1994
23
Broncholithiasis: a neglected bronchial disease in this country. Illustration of three cases. ( 1581838 )
1992
24
From alveoli back to bronchi. Contribution of bronchoalveolar (BAL) and bronchial (BL) lavage to the understanding of bronchial disease. International workshop. Verno, Italy, April 19-21, 1990. ( 1349762 )
1992
25
Cefetamet pivoxil (Ro 15-8075) and amoxicillin in the treatment of bacterial exacerbations of chronic bronchial disease--preliminary results. ( 16312635 )
1989
26
Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). ( 2470710 )
1989
27
Resection with laser and high frequency cutting loop in tracheo-bronchial diseases. ( 2715692 )
1989
28
Aspiration of solid food particles into lungs of patients with gastroesophageal reflux and chronic bronchial disease. ( 3338306 )
1988
29
Comparison of CT and fiberoptic bronchoscopy in the evaluation of bronchial disease. ( 3491497 )
1987
30
Beta-blockers and the patient with bronchial disease. ( 2879812 )
1986
31
Chronic bronchial disease of the cat. ( 3907110 )
1985
32
End-inspiratory flow reduction in the forced flow-volume curve as a sign of unilateral bronchial disease. ( 4080042 )
1985
33
No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases. ( 3907738 )
1985
34
Angiography in chest diseases. III. Chronic bronchial diseases, inflammatory, granulomatous, and fibrosing lung diseases. ( 6507202 )
1984
35
[Lipid analysis of sputum from patients with chronic bronchial diseases]. ( 7284646 )
1981
36
Bronchial disease in ulcerative colitis. ( 7444824 )
1980
37
Treatment of bronchial diseases in pediatrics. results of the use of oral acetylcysteine in 80 cases. ( 6938399 )
1980
38
Quantitative sputum gram stains in chronic bronchial disease. ( 43418 )
1979
39
Manual and computer methods for measuring lung mechanics in children with bronchial disease. ( 752398 )
1978
40
Anaerobic bacteriology of chronic bronchial disease. With a refined method of sampling bronchial secretions. ( 588430 )
1977
41
Physical properties of sputum and respiratory function in chronic bronchial disease. ( 4778954 )
1973
42
Relationship of physical sputum characteristics and ventilatory capacity in chronic bronchial disease. ( 4695750 )
1973
43
Sputum cell dynamics in bacterial exacerbations of chronic bronchial disease. ( 5019450 )
1972
44
The pattern of bacterial infection in bronchial diseases in Australia: a serological and bacteriological survey. ( 4404399 )
1972
45
Anhidrotic ectodermal dysplasia: predisposition to bronchial disease. ( 5539281 )
1971
46
Therapy of obstructive bronchial diseases: the physicochemical approach. ( 4107526 )
1971
47
Surgery for tracheal and bronchial diseases. ( 6075625 )
1967
48
Treatment of obstructive bronchial diseases. Periarterial sympathectomy with removal of carotid body. ( 5945214 )
1966
49
A BREATHING EXERCISE PROGRAM FOR CHRONIC BRONCHIAL DISEASE AND PULMONARY EMPHYSEMA. ( 14348275 )
1965
50
NATURAL HISTORY OF PLACEBO-TREATED PATIENTS WITH CHRONIC BRONCHIAL DISEASE OBSERVED FOR 7 YEARS. ( 14288021 )
1964

Variations for Bronchial Disease

Expression for Bronchial Disease

Search GEO for disease gene expression data for Bronchial Disease.

Pathways for Bronchial Disease

Pathways related to Bronchial Disease according to GeneCards Suite gene sharing:

(show all 38)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.9 CCL11 CCL5 CCR6 CXCL8 ELANE ICOSLG
2
Show member pathways
13.66 CCL11 CCL5 CCR6 CXCL8 IFNGR1 IL13
3
Show member pathways
13.54 CCL11 CCL5 CXCL8 IFNGR1 IL13 IL4
4
Show member pathways
13.42 CCL11 CCL5 CCR6 CXCL8 IL13 IL4
5
Show member pathways
13.33 CCL11 CCL5 CXCL8 IFNGR1 IL13 IL33
6
Show member pathways
13.31 CCL11 CCL5 CCR6 CXCL8 IL13 IL4
7 12.85 CXCL8 IFNGR1 IL13 IL4 IL5 STAT6
8
Show member pathways
12.76 CCL11 CXCL8 ICOSLG IFNGR1 IL13 IL4
9
Show member pathways
12.62 ICOSLG IFNGR1 IL4 MS4A2 TNF
10
Show member pathways
12.62 IFNGR1 IL13 IL4 IL5 STAT6 TNF
11
Show member pathways
12.58 IL13 IL4 IL5 MS4A2 TNF
12
Show member pathways
12.58 CCL5 CXCL8 IFNGR1 IL13 IL33 IL4
13
Show member pathways
12.41 IFNGR1 IL13 IL4 IL5 STAT6 TSLP
14
Show member pathways
12.35 CCL11 CXCL8 IL13 IL4 IL5 TNF
15
Show member pathways
12.3 CCL5 IL4 SERPINA3 TNF
16
Show member pathways
12.27 CXCL8 IL13 IL4 IL5 TNF
17
Show member pathways
12.21 CCL11 CXCL8 IFNGR1 IL4 TNF
18
Show member pathways
12.2 IFNGR1 IL33 STAT6 TNF
19
Show member pathways
12.07 CCL11 CCL5 CXCL8 IFNGR1 IL13 IL4
20
Show member pathways
12.01 CCL11 CCL5 CCR6 CXCL8
21 11.97 CCL11 CXCL8 IL13 IL4 STAT6 TNF
22 11.84 IL4 IL5 TNF
23 11.84 CXCL8 IL13 IL4 IL5
24 11.81 CCL5 CXCL8 TNF
25
Show member pathways
11.79 CXCL8 IL4 IL5 TNF
26 11.73 CCL11 CCL5 IL13 IL4 TNF
27 11.7 CCL11 IL4 IL5 STAT6
28 11.6 CCR6 IL13 IL33 IL4 IL5 TNF
29 11.54 CCL5 CXCL8 IL13 IL4 TNF
30 11.52 CCL11 CXCL8 STAT6 TSLP
31 11.4 CCL11 IL13 IL33 IL4 IL5 STAT6
32 11.26 IL13 IL4 IL5 TNF
33 11.22 IL13 IL4 IL5
34 11.18 CCL5 CXCL8 TNF
35 11.14 CCL11 CCL5 CXCL8 IL13 IL4 IL5
36 11.02 CCL11 CCL5 CXCL8 IL13 IL4 IL5
37 10.97 CCL11 CCL5 CXCL8 IL13 IL4 IL5
38 10.94 IL13 IL33 IL4 IL5 TNF TSLP

GO Terms for Bronchial Disease

Cellular components related to Bronchial Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.73 CCL11 CCL5 CXCL8 ELANE IL13 IL33
2 external side of plasma membrane GO:0009897 9.55 CCR6 ICOSLG IL13 MS4A2 TNF
3 azurophil granule lumen GO:0035578 9.43 ELANE RNASE3 SERPINA3
4 extracellular space GO:0005615 9.4 CCL11 CCL5 CXCL8 ELANE IL13 IL33

Biological processes related to Bronchial Disease according to GeneCards Suite gene sharing:

(show all 33)
# Name GO ID Score Top Affiliating Genes
1 defense response GO:0006952 9.86 CXCL8 CYSLTR1 ICOSLG TNF
2 inflammatory response GO:0006954 9.86 CCL11 CCL5 CXCL8 IL13 IL5 MS4A2
3 cellular calcium ion homeostasis GO:0006874 9.83 CCL11 CCL5 ELANE
4 immune response GO:0006955 9.81 CCL11 CCL5 CCR6 CXCL8 IL13 IL4
5 neutrophil chemotaxis GO:0030593 9.8 CCL11 CCL5 CXCL8
6 cellular response to interleukin-1 GO:0071347 9.8 CCL11 CCL5 CXCL8
7 response to virus GO:0009615 9.8 CCL11 CCL5 IFNGR1 TNF
8 chemotaxis GO:0006935 9.8 CCL11 CCL5 CCR6 CXCL8 CYSLTR1
9 positive regulation of inflammatory response GO:0050729 9.78 IL33 TNF TSLP
10 positive regulation of cold-induced thermogenesis GO:0120162 9.78 ADRB2 IL13 IL4 STAT6
11 chemokine-mediated signaling pathway GO:0070098 9.76 CCL11 CCL5 CCR6 CXCL8
12 positive regulation of interleukin-6 production GO:0032755 9.75 IL33 TNF TSLP
13 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.73 CCL5 IL13 IL4 TSLP
14 positive regulation of B cell proliferation GO:0030890 9.71 IL13 IL4 IL5
15 positive regulation of smooth muscle cell proliferation GO:0048661 9.67 CCL5 ELANE IL13 TNF
16 dendritic cell chemotaxis GO:0002407 9.66 CCL5 CCR6
17 positive regulation of macrophage activation GO:0043032 9.65 IL13 IL33
18 negative regulation of growth of symbiont in host GO:0044130 9.65 ELANE TNF
19 negative regulation of G protein-coupled receptor signaling pathway GO:0045744 9.64 CCL5 CXCL8
20 positive regulation of immunoglobulin secretion GO:0051024 9.64 IL33 IL5
21 positive regulation of podosome assembly GO:0071803 9.63 IL5 TNF
22 neutrophil activation GO:0042119 9.62 CCL5 CXCL8
23 positive regulation of chemokine secretion GO:0090197 9.61 IL33 TNF
24 regulation of signaling receptor activity GO:0010469 9.61 CCL11 CCL5 CXCL8 IL13 IL33 IL4
25 positive regulation of interleukin-8 biosynthetic process GO:0045416 9.6 ELANE TNF
26 leukocyte migration involved in inflammatory response GO:0002523 9.59 CCR6 ELANE
27 positive regulation of interleukin-5 production GO:0032754 9.58 IL33 TSLP
28 positive regulation of neuroinflammatory response GO:0150078 9.57 IL33 TNF
29 negative regulation of complement-dependent cytotoxicity GO:1903660 9.52 IL13 IL4
30 positive regulation of isotype switching to IgE isotypes GO:0048295 9.51 IL4 STAT6
31 positive regulation of interleukin-13 production GO:0032736 9.5 IL33 IL4 TSLP
32 cytokine-mediated signaling pathway GO:0019221 9.28 CCL11 CCL5 CXCL8 IFNGR1 IL13 IL4
33 signal transduction GO:0007165 10.2 ADRB2 CCL11 CCR6 CXCL8 CYSLTR1 ICOSLG

Molecular functions related to Bronchial Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.28 CCL11 CCL5 CXCL8 IL13 IL33 IL4
2 chemokine activity GO:0008009 9.13 CCL11 CCL5 CXCL8
3 protein binding GO:0005515 10.09 ADAM33 ADRB2 CCL11 CCL5 CCR6 CXCL8

Sources for Bronchial Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32